首页 > 最新文献

Laeknabladid最新文献

英文 中文
[Severe hidradenitis suppurativa treated with acellular fish skin - A case report and discussion of the disorder]. [无细胞鱼皮治疗严重化脓性汗腺炎1例报告及讨论]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 DOI: 10.17992/lbl.2025.11.864
Audur Gunnarsdottir, Elsa Bjork Valsdottir

Hidradenitis suppurativa is a chronic, debilitating disease due to recurrent infections, pain and foul smelling drainage. Presently, severe cases are treated with biologics. When surgery is needed it is usually extensive, requiring skin transplantation or flaps for closure. This case report presents a patient with severe disease on both buttocks, already treated with biologics. It was decided to attempt treatment with debridement and acellular fish skin to avoid extensive surgery. The treatment was successful, the patient is symptom-free on the right side 21 months after surgery and has minimal symptoms on the left side 7 months after surgery. He is contentwith the results.

化脓性汗腺炎是一种慢性衰弱疾病,由于反复感染,疼痛和恶臭排水。目前,重症病例用生物制剂治疗。当需要手术时,它通常是广泛的,需要皮肤移植或皮瓣关闭。本病例报告是一位双臀严重疾病患者,已接受生物制剂治疗。我们决定尝试清创和脱细胞鱼皮治疗,以避免广泛的手术。治疗成功,患者术后21个月右侧无症状,术后7个月左侧症状最小。他对结果很满意。
{"title":"[Severe hidradenitis suppurativa treated with acellular fish skin - A case report and discussion of the disorder].","authors":"Audur Gunnarsdottir, Elsa Bjork Valsdottir","doi":"10.17992/lbl.2025.11.864","DOIUrl":"10.17992/lbl.2025.11.864","url":null,"abstract":"<p><p>Hidradenitis suppurativa is a chronic, debilitating disease due to recurrent infections, pain and foul smelling drainage. Presently, severe cases are treated with biologics. When surgery is needed it is usually extensive, requiring skin transplantation or flaps for closure. This case report presents a patient with severe disease on both buttocks, already treated with biologics. It was decided to attempt treatment with debridement and acellular fish skin to avoid extensive surgery. The treatment was successful, the patient is symptom-free on the right side 21 months after surgery and has minimal symptoms on the left side 7 months after surgery. He is contentwith the results.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 11","pages":"482-486"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145460184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ventricular assist devices in Iceland 2010-2024]. [2010-2024年冰岛心室辅助装置]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2025-01-01 DOI: 10.17992/lbl.2025.10.858
Magnus Ari Brynleifsson, Aevar Orn Ulfarsson, Martin Ingi Sigurdsson

Introduction: Ventricular assist devices are increasingly used as a treatment option for patients with advanced heart failure, however, there is a lack of information about the number of patients, indications, and outcomes of this patient population in Iceland.

Methods and materials: A retrospective study covering the period 01.01.2020 - 31.12.2024. The study population consisted of individuals who had received a ventricular assist device and had received treatment or follow-up care in Iceland either before or after implantation of the ventricular assist device. Clinical data were obtained from electronic medical records, and variables were collected before and after implantation.

Results: Between 2010 and 2024, six individuals received a ventricular assist device (VAD), all of whom were male. The age at implantation ranged from 17 to 66 years. Indications for VAD implantation were equally divided between bridge to transplantation (3/6) and bridge to candidacy (3/6). The underlying causes of heart failure were dilated cardiomyopathy (5/6) and ischemic cardiomyopathy (1/6). Four patients received a left ventricular assist device, while two received a biventricular assist device. Four patients subsequently underwent heart transplantation, one died while on VAD support, and one remained on VAD therapy at the end of the study period. The mean time from VAD implantation to heart transplantation was 249 days. Throughout the study period, there were a total of 1704 days on which at least one patient with a VAD was located in Iceland, corresponding to 31% of the study period. Four complications were documented in three patients: driveline infection, ventricular tachycardia, gastrointestinal bleeding and subarachnoid hemorrhage due to syncope.

Conclusions: Patients with VADs were effectively managed in Iceland, and the results imply that the use of VADs possibly represents a currently underutilized therapeutic option for advanced heart failure in Iceland.

导读:心室辅助装置越来越多地被用作晚期心力衰竭患者的治疗选择,然而,冰岛缺乏有关患者数量、适应症和结果的信息。方法和材料:回顾性研究,时间为2020年1月1日- 2024年12月31日。研究人群包括接受心室辅助装置并在心室辅助装置植入前后在冰岛接受治疗或随访护理的个体。从电子病历中获取临床资料,并收集植入前后的变量。结果:2010年至2024年间,6名患者接受了心室辅助装置(VAD),均为男性。着床年龄从17岁到66岁不等。VAD植入适应症平均分为移植桥(3/6)和候选桥(3/6)。心衰的根本原因是扩张型心肌病(5/6)和缺血性心肌病(1/6)。4例患者接受左心室辅助装置,2例接受双心室辅助装置。4名患者随后接受了心脏移植,1名患者在使用VAD支持时死亡,1名患者在研究结束时仍在使用VAD治疗。从VAD植入到心脏移植的平均时间为249天。在整个研究期间,总共有1704天至少有一名VAD患者位于冰岛,占研究期间的31%。3例患者出现4种并发症:传动系统感染、室性心动过速、胃肠道出血和晕厥所致的蛛网膜下腔出血。结论:在冰岛,VADs患者得到了有效的管理,结果表明VADs的使用可能是目前冰岛晚期心力衰竭未充分利用的治疗选择。
{"title":"[Ventricular assist devices in Iceland 2010-2024].","authors":"Magnus Ari Brynleifsson, Aevar Orn Ulfarsson, Martin Ingi Sigurdsson","doi":"10.17992/lbl.2025.10.858","DOIUrl":"https://doi.org/10.17992/lbl.2025.10.858","url":null,"abstract":"<p><strong>Introduction: </strong>Ventricular assist devices are increasingly used as a treatment option for patients with advanced heart failure, however, there is a lack of information about the number of patients, indications, and outcomes of this patient population in Iceland.</p><p><strong>Methods and materials: </strong>A retrospective study covering the period 01.01.2020 - 31.12.2024. The study population consisted of individuals who had received a ventricular assist device and had received treatment or follow-up care in Iceland either before or after implantation of the ventricular assist device. Clinical data were obtained from electronic medical records, and variables were collected before and after implantation.</p><p><strong>Results: </strong>Between 2010 and 2024, six individuals received a ventricular assist device (VAD), all of whom were male. The age at implantation ranged from 17 to 66 years. Indications for VAD implantation were equally divided between bridge to transplantation (3/6) and bridge to candidacy (3/6). The underlying causes of heart failure were dilated cardiomyopathy (5/6) and ischemic cardiomyopathy (1/6). Four patients received a left ventricular assist device, while two received a biventricular assist device. Four patients subsequently underwent heart transplantation, one died while on VAD support, and one remained on VAD therapy at the end of the study period. The mean time from VAD implantation to heart transplantation was 249 days. Throughout the study period, there were a total of 1704 days on which at least one patient with a VAD was located in Iceland, corresponding to 31% of the study period. Four complications were documented in three patients: driveline infection, ventricular tachycardia, gastrointestinal bleeding and subarachnoid hemorrhage due to syncope.</p><p><strong>Conclusions: </strong>Patients with VADs were effectively managed in Iceland, and the results imply that the use of VADs possibly represents a currently underutilized therapeutic option for advanced heart failure in Iceland.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"111 10","pages":"421-427"},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The Nobel prize in medicine - microRNA and gene regulation]. [诺贝尔医学奖- microRNA和基因调控]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-01 DOI: 10.17992/lbl.2024.12.816
Eirikur Steingrimsson, Magnus Karl Magnusson
{"title":"[The Nobel prize in medicine - microRNA and gene regulation].","authors":"Eirikur Steingrimsson, Magnus Karl Magnusson","doi":"10.17992/lbl.2024.12.816","DOIUrl":"https://doi.org/10.17992/lbl.2024.12.816","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 12","pages":"557"},"PeriodicalIF":0.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774166","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Food as migraine trigger]. [食物引发偏头痛]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-01 DOI: 10.17992/lbl.2024.12.818
Hadda Margret Haraldsdottir, Ingibjorg Gunnarsdottir, Arora Ros Ingadottir, Olafur Sveinsson

Background and aims: Migraine is a neurological disorder that is characterized by severe headaches and temporary motor and sensory disturbances. Migraine triggers are internal or external factors that can increase the likelihood of a migraine attack. Some individuals with migraine associate their attacks with the consumption of certain types of food, but no have been conducted in Iceland. The aim of the study was to estimate the proportion of individuals with migraine in Iceland who associate their symptoms with consuming certain types of food.

Methods: An electronic questionnaire was submitted to two groups (≥18 years old), members of the Icelandic Facebook group 'Migreni' (n=395 and to patients being treated by a neurologist (n=108), with the question if they thought certain foods could trigger migraine attacks. A total of 503 opened the survey (19.6% in the Facebook group and 65% managed by a neurologist). Response options were never/rarely, sometimes, often, or always. Other questions included types of migraine, medication use and background.

Results: Out of 466 participants, 354 individuals (76%) claimed that food often or always triggered their migraine. The proportion was higher in the Facebook group than in the neurologist group (78% vs. 66%, p=0.007). Red wine and skipping meals (hunger) were the most common food-related triggers, reported as triggers often or always by >50%. Other common food triggers included white wine, liquorice, and smoked meat; they were reported as triggers by 20-50% of participants.

Conclusion: Food seems to be a common migraine trigger, and the main food-related triggers were similar to those reported in other studies. However, previous studies have not shown liquorice as a common food trigger for migraines, and smoked meat was found to be a more common trigger than seen in other studies.

背景和目的:偏头痛是一种神经系统疾病,其特征是严重的头痛和暂时的运动和感觉障碍。偏头痛的诱因是可以增加偏头痛发作可能性的内部或外部因素。一些偏头痛患者将他们的发作与食用某些食物联系起来,但在冰岛没有进行过这样的研究。这项研究的目的是估计冰岛偏头痛患者的比例,他们的症状与食用某些类型的食物有关。方法:向两组(≥18岁)提交电子问卷,一组是冰岛Facebook小组“Migreni”的成员(n=395),另一组是正在接受神经科医生治疗的患者(n=108),问题是他们是否认为某些食物会引发偏头痛发作。共有503人参与了调查(19.6%在Facebook组,65%由神经科医生管理)。回答选项是never/rarely, sometimes, often, always。其他问题包括偏头痛的类型、药物使用和背景。结果:在466名参与者中,354人(76%)声称食物经常或总是引发偏头痛。Facebook组的比例高于神经科医生组(78%对66%,p=0.007)。红酒和不吃饭(饥饿)是最常见的与食物有关的诱因,据报道,经常或总是有50%的诱因。其他常见的食物诱发因素包括白葡萄酒、甘草和烟熏肉;20-50%的参与者认为它们是触发因素。结论:食物似乎是常见的偏头痛诱因,主要的食物相关诱因与其他研究报告相似。然而,之前的研究并没有显示甘草是偏头痛的常见食物诱因,而熏肉被发现是比其他研究更常见的诱因。
{"title":"[Food as migraine trigger].","authors":"Hadda Margret Haraldsdottir, Ingibjorg Gunnarsdottir, Arora Ros Ingadottir, Olafur Sveinsson","doi":"10.17992/lbl.2024.12.818","DOIUrl":"https://doi.org/10.17992/lbl.2024.12.818","url":null,"abstract":"<p><strong>Background and aims: </strong>Migraine is a neurological disorder that is characterized by severe headaches and temporary motor and sensory disturbances. Migraine triggers are internal or external factors that can increase the likelihood of a migraine attack. Some individuals with migraine associate their attacks with the consumption of certain types of food, but no have been conducted in Iceland. The aim of the study was to estimate the proportion of individuals with migraine in Iceland who associate their symptoms with consuming certain types of food.</p><p><strong>Methods: </strong>An electronic questionnaire was submitted to two groups (≥18 years old), members of the Icelandic Facebook group 'Migreni' (n=395 and to patients being treated by a neurologist (n=108), with the question if they thought certain foods could trigger migraine attacks. A total of 503 opened the survey (19.6% in the Facebook group and 65% managed by a neurologist). Response options were never/rarely, sometimes, often, or always. Other questions included types of migraine, medication use and background.</p><p><strong>Results: </strong>Out of 466 participants, 354 individuals (76%) claimed that food often or always triggered their migraine. The proportion was higher in the Facebook group than in the neurologist group (78% vs. 66%, p=0.007). Red wine and skipping meals (hunger) were the most common food-related triggers, reported as triggers often or always by >50%. Other common food triggers included white wine, liquorice, and smoked meat; they were reported as triggers by 20-50% of participants.</p><p><strong>Conclusion: </strong>Food seems to be a common migraine trigger, and the main food-related triggers were similar to those reported in other studies. However, previous studies have not shown liquorice as a common food trigger for migraines, and smoked meat was found to be a more common trigger than seen in other studies.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 12","pages":"564-570"},"PeriodicalIF":0.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[New treatment perspectives in chronic kidney disease]. [慢性肾脏疾病治疗的新观点]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-01 DOI: 10.17992/lbl.2024.12.815
Fjolnir Elvarsson
{"title":"[New treatment perspectives in chronic kidney disease].","authors":"Fjolnir Elvarsson","doi":"10.17992/lbl.2024.12.815","DOIUrl":"https://doi.org/10.17992/lbl.2024.12.815","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 12","pages":"555"},"PeriodicalIF":0.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[SGLT2 inhibitors - A novel treatment for congestive heart failure and chronic kidney disease]. [SGLT2抑制剂-一种治疗充血性心力衰竭和慢性肾脏疾病的新方法]。
IF 0.4 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-12-01 DOI: 10.17992/lbl.2024.12.817
Sigridur Birna Eliasdottir

SGLT2 inhibitors increase renal excretion of sodium and glucose by blocking the SGLT2 transporters in the proximal tubule. Not only do they lower blood sugars levels but also have positive effects on blood pressure and weight. They lead to more efficient energy metabolism in the heart and kidneys, increase the production of red blood cells and decrease fibrosis and inflammation in the heart and the kidneys. Large double blind randomized trials have shown both cardiac and renal protective effects. Patient with heart failure, both with reduced and preserved ejection fraction have shown to benefit from treatment with SGLT2 inhibitors. They have lower risk of death due to cardiovascular causes and decreased risk of hospitalization because of heart failure compared to patient treated with placebo both with and without diabetes type 2. SGLT2 inhibitors are shown to decrease risk of chronic kidney disease stage 5 and dialysis, death due of cardiovascular events and doubling of serum creatinine in patients with chronic kidney disease both with and without diabetes type 2. They are now recommended for treatment of heart failure and chronic kidney disease with the highest evidence grade. SGLT2 inhibitors do not increase risk of hypoglycemia or acute kidney injury but do have a serious uncommon adverse effect that are normoglycemic ketoacidosis and Fournier's gangrene that physicians need to be alert to.

SGLT2抑制剂通过阻断近端小管中的SGLT2转运蛋白而增加钠和葡萄糖的肾脏排泄。它们不仅能降低血糖水平,而且对血压和体重也有积极的影响。它们能提高心脏和肾脏的能量代谢效率,增加红细胞的产生,减少心脏和肾脏的纤维化和炎症。大型双盲随机试验显示其对心脏和肾脏均有保护作用。射血分数降低和保留的心力衰竭患者均可从SGLT2抑制剂治疗中获益。与接受安慰剂治疗的2型糖尿病患者相比,他们因心血管原因死亡的风险较低,因心力衰竭住院的风险也较低。研究显示,SGLT2抑制剂可降低慢性肾脏疾病5期和透析的风险、心血管事件导致的死亡,并可使伴有和不伴有2型糖尿病的慢性肾脏疾病患者血清肌酐翻倍。它们现在被推荐用于治疗心力衰竭和慢性肾脏疾病,证据等级最高。SGLT2抑制剂不会增加低血糖或急性肾损伤的风险,但确实有严重的不常见的不良反应,如血糖正常的酮症酸中毒和富尼耶坏疽,医生需要警惕。
{"title":"[SGLT2 inhibitors - A novel treatment for congestive heart failure and chronic kidney disease].","authors":"Sigridur Birna Eliasdottir","doi":"10.17992/lbl.2024.12.817","DOIUrl":"https://doi.org/10.17992/lbl.2024.12.817","url":null,"abstract":"<p><p>SGLT2 inhibitors increase renal excretion of sodium and glucose by blocking the SGLT2 transporters in the proximal tubule. Not only do they lower blood sugars levels but also have positive effects on blood pressure and weight. They lead to more efficient energy metabolism in the heart and kidneys, increase the production of red blood cells and decrease fibrosis and inflammation in the heart and the kidneys. Large double blind randomized trials have shown both cardiac and renal protective effects. Patient with heart failure, both with reduced and preserved ejection fraction have shown to benefit from treatment with SGLT2 inhibitors. They have lower risk of death due to cardiovascular causes and decreased risk of hospitalization because of heart failure compared to patient treated with placebo both with and without diabetes type 2. SGLT2 inhibitors are shown to decrease risk of chronic kidney disease stage 5 and dialysis, death due of cardiovascular events and doubling of serum creatinine in patients with chronic kidney disease both with and without diabetes type 2. They are now recommended for treatment of heart failure and chronic kidney disease with the highest evidence grade. SGLT2 inhibitors do not increase risk of hypoglycemia or acute kidney injury but do have a serious uncommon adverse effect that are normoglycemic ketoacidosis and Fournier's gangrene that physicians need to be alert to.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 12","pages":"558-563"},"PeriodicalIF":0.4,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142774165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anyone can contract HIV but no one should get AIDS]. 任何人都可能感染艾滋病毒,但不应该得艾滋病。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.17992/lbl.2024.11.813
Katrin Holmgrimsdottir, Saemundur Rognvaldsson, Telma Huld Ragnarsdottir, Erna Milunka Kojic

HIV can have various clinical manifestations and without treatment it can progress to AIDS and have severe complications. We have effective treatments against the infection and want to treat everyone with HIV before it progresses to AIDS. The premise for that is HIV testing. HIV infection should be on the differential when patients present with signs and symptoms not otherwise explained. We describe here two recent cases of AIDS in Icelandic women that did not have perceived risk factors resulting in a significant delay in HIV diagnosis leading to AIDS.

艾滋病毒可以有各种临床表现,如果不进行治疗,它可以发展为艾滋病,并有严重的并发症。我们有有效的治疗方法来对抗这种感染,并希望在每个艾滋病毒感染者发展为艾滋病之前对其进行治疗。前提是艾滋病毒检测。当患者出现其他无法解释的体征和症状时,应注意艾滋病毒感染。我们在这里描述了冰岛妇女最近的两例艾滋病病例,这些病例没有意识到导致艾滋病毒诊断严重延误的危险因素,从而导致艾滋病。
{"title":"[Anyone can contract HIV but no one should get AIDS].","authors":"Katrin Holmgrimsdottir, Saemundur Rognvaldsson, Telma Huld Ragnarsdottir, Erna Milunka Kojic","doi":"10.17992/lbl.2024.11.813","DOIUrl":"10.17992/lbl.2024.11.813","url":null,"abstract":"<p><p>HIV can have various clinical manifestations and without treatment it can progress to AIDS and have severe complications. We have effective treatments against the infection and want to treat everyone with HIV before it progresses to AIDS. The premise for that is HIV testing. HIV infection should be on the differential when patients present with signs and symptoms not otherwise explained. We describe here two recent cases of AIDS in Icelandic women that did not have perceived risk factors resulting in a significant delay in HIV diagnosis leading to AIDS.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 11","pages":"512-515"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Meckel's diverticulitis with perforation - a case report and discussion of the disorder]. [梅克尔憩室炎伴穿孔-一例报告及疾病讨论]。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.17992/lbl.2024.11.814
Gudrun Margret Vidarsdottir, Hulda Maria Einarsdottir, Jon Gunnlaugur Jonasson, Pall Helgi Moller

Meckel's diverticulum is a common congenital anomaly in embryonic development of the ileum. Meckel's diverticulum is most often asymptomatic, but complications can arise, such as gastrointestinal bleeding and diverticulitis. We present a case report of a 42-year-old man who was diagnosed with Meckel's diverticulitis with perforation and had a previous history of gastrointestinal bleeding.

梅克尔憩室是回肠胚胎发育中一种常见的先天性异常。梅克尔憩室通常无症状,但可能出现并发症,如胃肠道出血和憩室炎。我们提出一个病例报告,42岁的男子谁被诊断为梅克尔憩室炎穿孔,并有消化道出血的历史。
{"title":"[Meckel's diverticulitis with perforation - a case report and discussion of the disorder].","authors":"Gudrun Margret Vidarsdottir, Hulda Maria Einarsdottir, Jon Gunnlaugur Jonasson, Pall Helgi Moller","doi":"10.17992/lbl.2024.11.814","DOIUrl":"10.17992/lbl.2024.11.814","url":null,"abstract":"<p><p>Meckel's diverticulum is a common congenital anomaly in embryonic development of the ileum. Meckel's diverticulum is most often asymptomatic, but complications can arise, such as gastrointestinal bleeding and diverticulitis. We present a case report of a 42-year-old man who was diagnosed with Meckel's diverticulitis with perforation and had a previous history of gastrointestinal bleeding.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 11","pages":"516-519"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cervical artery dissection in Iceland: epidemiology, treatment and prognosis]. 冰岛颈动脉夹层:流行病学、治疗和预后。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.17992/lbl.2024.11.812
Idunn Andradottir, Brynhildur Thors, Olafur Sveinsson

Background: Cervical artery dissection is a common cause of ischemic stroke in young adults and middle-aged individuals. Due to advances in imaging techniques and increased knowledge, dissections are now diagnosed much more frequently than before. This study aimed to investigate the incidence of cervical artery dissection in Iceland from 2005 to 2023.

Methods: A retrospective study was conducted using medical records of individuals diagnosed with cervical artery dissection in Iceland between January 1, 2005, and December 31, 2023. The factors examined included gender, year of diagnosis, age at diagnosis, symptoms, risk factors, treatment, and prognosis. Data processing was performed using Excel® and Rstudio.

Results: The study sample consisted of 107 individuals, including 37 women and 70 men. The average incidence was 1.62 per 100,000 people per year. The incidence increased over the period, being 2.7 times higher in the latter half compared to the former. The average age of diagnosis was 50 years (range 18-101 years). The most common symptom was pain (72%), followed by sensory disturbances (67%), motor disturbances (49%), and Horner's syndrome (36%). Half of the patients experienced an ischemic stroke (51%). Five individuals (4.6%) had a recurrent dissection during the follow-up period. Dissections occurred in the internal carotid artery in 56% of cases and the vertebral artery in 44% of cases. All patients received antiplatelet and/or anticoagulant therapy. After 3-6 months, 77% had no or mild disability (0-2 on the modified Rankin scale).

Discussion: The incidence of cervical artery dissection in Iceland is consistent with findings from other studies. Diagnoses have increased in recent years, and the average incidence has risen. The majority of patients achieved good recovery, indicating effective diagnosis and treatment of cervical artery dissection in Iceland.

背景:颈动脉夹层是青壮年和中年人缺血性脑卒中的常见原因。由于影像技术的进步和知识的增加,现在的解剖诊断比以前频繁得多。本研究旨在调查2005年至2023年冰岛颈动脉夹层的发生率。方法:回顾性研究2005年1月1日至2023年12月31日期间冰岛诊断为颈动脉夹层患者的医疗记录。检查的因素包括性别、诊断年份、诊断年龄、症状、危险因素、治疗和预后。使用Excel®和Rstudio进行数据处理。结果:研究样本包括107个人,其中37名女性和70名男性。平均发病率为每年每10万人中有1.62人。在此期间,发病率有所增加,后半期的发病率是前半期的2.7倍。平均诊断年龄50岁(范围18-101岁)。最常见的症状是疼痛(72%),其次是感觉障碍(67%)、运动障碍(49%)和霍纳综合征(36%)。一半的患者经历了缺血性中风(51%)。5人(4.6%)在随访期间出现复发性夹层。56%的病例发生颈内动脉夹层,44%的病例发生椎动脉夹层。所有患者均接受抗血小板和/或抗凝治疗。3-6个月后,77%的患者无残疾或轻度残疾(改良Rankin量表0-2分)。讨论:冰岛颈动脉夹层的发生率与其他研究结果一致。近年来诊断有所增加,平均发病率也有所上升。大多数患者恢复良好,表明冰岛颈动脉夹层的诊断和治疗是有效的。
{"title":"[Cervical artery dissection in Iceland: epidemiology, treatment and prognosis].","authors":"Idunn Andradottir, Brynhildur Thors, Olafur Sveinsson","doi":"10.17992/lbl.2024.11.812","DOIUrl":"10.17992/lbl.2024.11.812","url":null,"abstract":"<p><strong>Background: </strong>Cervical artery dissection is a common cause of ischemic stroke in young adults and middle-aged individuals. Due to advances in imaging techniques and increased knowledge, dissections are now diagnosed much more frequently than before. This study aimed to investigate the incidence of cervical artery dissection in Iceland from 2005 to 2023.</p><p><strong>Methods: </strong>A retrospective study was conducted using medical records of individuals diagnosed with cervical artery dissection in Iceland between January 1, 2005, and December 31, 2023. The factors examined included gender, year of diagnosis, age at diagnosis, symptoms, risk factors, treatment, and prognosis. Data processing was performed using Excel® and Rstudio.</p><p><strong>Results: </strong>The study sample consisted of 107 individuals, including 37 women and 70 men. The average incidence was 1.62 per 100,000 people per year. The incidence increased over the period, being 2.7 times higher in the latter half compared to the former. The average age of diagnosis was 50 years (range 18-101 years). The most common symptom was pain (72%), followed by sensory disturbances (67%), motor disturbances (49%), and Horner's syndrome (36%). Half of the patients experienced an ischemic stroke (51%). Five individuals (4.6%) had a recurrent dissection during the follow-up period. Dissections occurred in the internal carotid artery in 56% of cases and the vertebral artery in 44% of cases. All patients received antiplatelet and/or anticoagulant therapy. After 3-6 months, 77% had no or mild disability (0-2 on the modified Rankin scale).</p><p><strong>Discussion: </strong>The incidence of cervical artery dissection in Iceland is consistent with findings from other studies. Diagnoses have increased in recent years, and the average incidence has risen. The majority of patients achieved good recovery, indicating effective diagnosis and treatment of cervical artery dissection in Iceland.</p>","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 11","pages":"506-511"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Early HIV Detection: Key to Preventing AIDS]. 早期发现HIV:预防艾滋病的关键。
IF 0.6 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-11-01 DOI: 10.17992/lbl.2024.11.811
Gudrun Aspelund
{"title":"[Early HIV Detection: Key to Preventing AIDS].","authors":"Gudrun Aspelund","doi":"10.17992/lbl.2024.11.811","DOIUrl":"10.17992/lbl.2024.11.811","url":null,"abstract":"","PeriodicalId":49924,"journal":{"name":"Laeknabladid","volume":"110 11","pages":"505"},"PeriodicalIF":0.6,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144838422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Laeknabladid
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1